Empirical implications of physician authority in pharmaceutical decisionmaking
Read Online
Share

Empirical implications of physician authority in pharmaceutical decisionmaking by Scott Stern

  • 609 Want to read
  • ·
  • 12 Currently reading

Published by National Bureau of Economic Research in Cambridge, MA .
Written in English

Subjects:

  • Drugs -- Prescribing -- Econometric models.,
  • Prescription pricing -- Econometric models.,
  • Advertising -- Drugs -- Econometric models.

Book details:

Edition Notes

Other titlesPhysician authority in pharmaceutical decisionmaking
StatementScott Stern, Manuel Trajtenberg.
SeriesNBER working paper series -- working paper 6851, Working paper series (National Bureau of Economic Research) -- working paper no. 6851.
ContributionsTrajtenberg, Manuel., National Bureau of Economic Research.
Classifications
LC ClassificationsHB1 .W654 no. 6851, RM138 .S74 1998
The Physical Object
Pagination30, [14] p. :
Number of Pages30
ID Numbers
Open LibraryOL22400652M

Download Empirical implications of physician authority in pharmaceutical decisionmaking

PDF EPUB FB2 MOBI RTF

Empirical implications of physician authority in pharmaceutical decisionmaking Author: Scott Stern ; Manuel Trajtenberg ; National Bureau of Economic Research. Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking This paper studies the consequences of physician authority on pharmaceutical prescribing. Physicians engage in a costly process of "matching" patients to the drug which . This paper studies the consequences of physician authority on pharmaceutical prescribing. Physicians engage in a costly process of particular conditions and characteristics. The relative efficiency of this matching process results from the diagnostic skill of the physician along with the investments made by the doctor in learning about different : Scott Stern and Manuel Trajtenberg. Published: Patient Welfare and Patient Compliance -- An Empirical Framework for Measuring the Benefits from Pharmaceutical Innovation, Paul Ellickson, Scott Stern, Manuel Trajtenberg. in Medical Care Output and Productivity, Cutler and Berndt. Cited by:

"Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking," NBER Working Papers , National Bureau of Economic Research, Inc. Tomas Philipson & Larry V. Hedges, " Subject Evaluation in Social Experiments," Econometrica, Econometric Society, . "Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking," NBER Working Papers , National Bureau of Economic Research, Inc. Darby, Michael R & Karni, Edi, " Free Competition and the Optimal Amount of Fraud," Journal of Law and Economics, University of Chicago Press, vol. 16(1), pages , April. "Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking," Papers , Tel Aviv. Scott Stern & Manuel Trajtenberg, " Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking," NBER Working Papers , National Bureau of . (). Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking” (). Estimating Discrete choice model of product differentiation”. (). Facts and Figures. Norwegian Association of Pharmaceutical Manufacturers. ().

"Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking," NBER Working Papers , National Bureau of Economic Research, Inc. Helpman, E. & Trajtenberg, M., " Diffusion of General Purpose Technologies," Papers , Tel Aviv - . Empirical implications of physician authority in pharmaceutical decisionmaking: A general purpose technology at work: the Corliss steam engine in the late 19th century US: Geographic localization of knowledge spillovers as evidenced by patent citations: Innovation in Israel, a comparative analysis using patent data. Ellickson, Stern, and Trajtenberg: w Patient Welfare and Patient Compliance: An Empirical Framework for Measuring the Benefits from Pharmaceutical Innovation: Stern and Trajtenberg: w Empirical Implications of Physician Authority in Pharmaceutical Decisionmaking: Meltzer: Theoretical Foundations of Medical Cost-Effectiveness Analysis -- Implications for the Measurement Cited by: Medical practitioners and the pharmaceutical industry serve interests that sometimes overlap and sometimes conflict. There is strong evidence that associations between industry and doctors influence the behaviour of the latter in relation to both clinical decision making and the conduct of by: